As shown in Figure 1, patients who had peritoneal metastases had significantly higher levels of ALCAM than those without (p = 0.037 for gastric cancer (Figure 1A) and p = 0.01 for pancreatic cancer (Figure 1B)). This evidence concerns the gene ALCAM and pancreatic neoplasm.